SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 558.43 |
Enterprise Value ($M) | 490.57 |
Book Value ($M) | 290.10 |
Book Value / Share | 5.83 |
Price / Book | 1.92 |
NCAV ($M) | 289.60 |
NCAV / Share | 5.82 |
Price / NCAV | 1.93 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.41 |
Return on Assets (ROA) | -0.41 |
Return on Equity (ROE) | -0.42 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 11.20 |
Current Ratio | 11.20 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 318.00 |
Assets | 318.49 |
Liabilities | 28.40 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -84.66 |
Net Income | -71.90 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -81.17 |
Cash from Investing | -160.47 |
Cash from Financing | 203.25 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | TCG Crossover GP II, LLC | 6.40 | ||
13G | Adams Street Partners Llc | 5.60 | ||
13G | HBM Healthcare Investments (Cayman) Ltd. | 5.50 | ||
13G | Catalys Pacific Fund, LP | 22.40 | ||
13D/A | Samsara BioCapital, L.P. | 10.30 | 12.61 | |
13D/A | Ra Capital Management, L.p. | 9.99 | 55.59 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
11,060 | 51,888 | 21.32 | |
18,063 | 75,124 | 24.04 | |
16,928 | 71,099 | 23.81 | |
15,343 | 46,121 | 33.27 | |
(click for more detail) |
Similar Companies | |
---|---|
MGNX – MacroGenics, Inc. | MGTX – MeiraGTx Holdings plc |
MIST – Milestone Pharmaceuticals Inc. | MNMD – Mind Medicine (MindMed) Inc. |
MRNA – Moderna, Inc. |
Financial data and stock pages provided by
Fintel.io